🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Immunovia AB (publ) (STO:IMMNOV)
Sweden flag Sweden · Delayed Price · Currency is SEK
0.0371
+0.0042 (12.77%)
Nov 19, 2026, 1:54 PM CET

Immunovia AB Revenue

Immunovia AB had revenue of 888.00K SEK in the quarter ending September 30, 2026, with 779.21% growth. This brings the company's total for the last twelve months to 2.07M, up 129.20% year-over-year. In the year 2025, Immunovia AB had annual revenue of 752.00K, down -55.61%. That makes Immunovia AB the 45,548th largest company in the world by revenue and 724th in Sweden.

Revenue (ttm)
2.07M
Revenue Growth
+129.20%
P/S Ratio
11.33
Revenue / Employee
102.79K
Employees
19
Market Cap
24.96M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025752.00K-942.00K-55.61%
Dec 31, 20241.69M-108.00K-5.99%
Dec 31, 20231.80M598.00K49.67%
Dec 31, 20221.20M248.00K25.94%
Dec 31, 2021956.00K-30.00K-3.04%
Dec 31, 2020986.00K172.00K21.13%
Dec 31, 2019814.00K-263.00K-24.42%
Dec 31, 20181.08M-23.17M-95.56%
Dec 31, 201724.25M-254.10K-1.04%
Dec 31, 201624.50M7.50M44.07%
Dec 31, 201517.01M16.47M3,084.89%
Dec 31, 2014534.00K-646.09K-54.75%
Dec 31, 20131.18M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Immunovia AB News

More News